Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)
Carlos Aguado de la Rosa,Patricia Cruz Castellanos,Martín Lázaro-Quintela,Manuel Dómine,Sergio Vázquez Estévez,Guillermo López-Vivanco,José Luis Fírvida Pérez,José Luis Alonso Romero, Lioba Ferrera Delgado,Carlos García Girón,Pilar Diz Taín,Rosa Álvarez Álvarez,Pilar Mut Sanchís, Inmaculada Fernández Cantón, Isabel Manrique Abós,Maite Martínez Aguillo, Lorenzo Gómez-Aldaraví Gutiérrez,Ana Laura Ortega Granados, Ruth Álvarez Cabellos, Arancha García Sebastián Lung Cancer（2022）
关键词
Anaplastic lymphoma kinase,ALK-positive non-small cell lung cancer (NSCLC),Crizotinib,Real-world,Incidence,Tyrosine kinase inhibitors
AI 理解论文
溯源树
样例
